Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Longacre, Teri A."" wg kryterium: Autor


Wyświetlanie 1-7 z 7
Tytuł:
Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium.
Autorzy:
Longacre TA; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
Broaddus R; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
Chuang LT; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
Cohen MB; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
Jarboe EA; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
Mutter GL; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
Otis CN; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
Zaino RJ; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
Pokaż więcej
Corporate Authors:
Members of the Cancer Biomarker Reporting Committee, College of American Pathologists; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2017 Nov; Vol. 141 (11), pp. 1508-1512. Date of Electronic Publication: 2017 Mar 16.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor/*analysis
Carcinoma/*metabolism
Endometrial Neoplasms/*metabolism
Research Report/*standards
Carcinoma/diagnosis ; Endometrial Neoplasms/diagnosis ; Endometrium/metabolism ; Endometrium/pathology ; Female ; Guidelines as Topic/standards ; Humans
Czasopismo naukowe
Tytuł:
Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase ε (POLE).
Autorzy:
Forgó, Erna
Gomez, Adam J
Steiner, David
Zehnder, James
Longacre, Teri A
Pokaż więcej
Temat:
DNA polymerases
EXONUCLEASES
CARCINOMA
SOMATIC mutation
COLON (Anatomy)
NUCLEOTIDE sequencing
Źródło:
Histopathology; Feb2020, Vol. 76 Issue 3, p366-374, 9p, 4 Diagrams, 2 Charts, 1 Graph
Czasopismo naukowe
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies